HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double-pulse defibrillation using pulse separation based on the fibrillation cycle length.

AbstractINTRODUCTION:
We investigated a method of defibrillation in which two shocks were delivered to the same electrodes with a separation based on the cycle length of the fibrillation event (FCL).
METHODS AND RESULTS:
In pentobarbital anesthetized dogs, a computerized system determined the FCL from the fibrillation event, computed the desired double-pulse (DP) shock separation, and immediately delivered the DP shocks. In group 1, energy for 50% success at defibrillation (E50) was measured using separations from 55% to 95% of the FCL and remeasured after administration of flecainide, clofilium, or vehicle to change the FCL. Both drugs increased FCL by approximately 25%. Plots of E50 versus %FCL aligned before and after drug showed that the optimum pulse separation followed the FCL. In group 2, E50s were measured for 55% to 185% FCL separations in clofilium or vehicle-treated animals. The optimum DP E50 was at 85% FCL and was not significantly different from the single-shock E50. In group 3, no differences were found when comparing the probability of success versus total energy relationships for single and optimum DP shocks. Group 4 compared E50s for single and DP shocks using a single-catheter configuration and three-electrode configurations (catheter-subdermal patch). E50s for single and DP shocks were equal using the single-catheter configuration but DP shocks required approximately 20% more energy in the three-electrode configurations.
CONCLUSION:
In single-pathway lead configurations, two shocks with 85% FCL separation can be reliably combined to defibrillate using the same total energy as a larger single shock. Since the energy is unchanged but the total duration is doubled, DP shock currents are reduced by 20% to 30%.
AuthorsR J Sweeney, R M Gill, P R Reid
JournalJournal of cardiovascular electrophysiology (J Cardiovasc Electrophysiol) Vol. 5 Issue 9 Pg. 761-70 (Sep 1994) ISSN: 1045-3873 [Print] United States
PMID7827715 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Arrhythmia Agents
Topics
  • Animals
  • Anti-Arrhythmia Agents (pharmacology)
  • Defibrillators, Implantable
  • Dogs
  • Electric Countershock (methods)
  • Electrocardiography
  • Female
  • Male
  • Ventricular Fibrillation (physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: